IL17A and infection: However de Steenwinkel et al. (2012) [7] found that levels in treated mice were lower than in placebo treated mice after five weeks of therapy whereas in our study IL-17 and IL-6 levels in infected mice had already decreased to baseline before therapy was initialized (6 weeks after infection; Figure 2).